Section Arrow
TXMD.NASDAQ
- TherapeuticsMD
Quotes are at least 15-min delayed:2025/02/22 17:54 EST
Last
 1.291
+0.281 (+27.82%)
Day High 
1.66 
Prev. Close
1.01 
1-M High
1.18 
Volume 
14.00M 
Bid
1.22
Ask
1.23
Day Low
1.025 
Open
1.05 
1-M Low
0.95 
Market Cap 
11.65M 
Currency USD 
P/E 0.39 
%Yield -- 
10-SMA 1.02 
20-SMA 1.05 
50-SMA 1.11 
52-W High 2.75 
52-W Low 0.7 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.27/0.17
Enterprise Value
18.18M
Balance Sheet
Book Value Per Share
2.35
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
1.30M
Operating Revenue Per Share
6.05
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
UPCUniverse Pharmaceuticals Inc0.2003+0.0578+40.56%-- 
TLRYTilray Brands0.9452+0.0775+8.93%-- 
CGCCanopy Growth Corp1.615+0.005+0.31%-- 
TXMDTherapeuticsMD1.291+0.281+27.82%0.39PE
TEVATeva Pharmaceutical Industries Limited16.74-0.26-1.53%-- 
Quotes are at least 15-min delayed:2025/02/22 17:54 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.